Filter
509
Text search:
microbiological
risk
assessment
Featured
Recommendations
73
New Publications
137
Language
Document type
No document type
254
Guidelines
110
Studies & Reports
74
Manuals
46
Strategic & Response Plan
14
Situation Updates
6
Training Material
3
Brochures
1
Fact sheets
1
Countries / Regions
India
48
Western and Central Europe
19
Global
14
Ethiopia
11
Kenya
11
South Africa
11
Tanzania
10
Bangladesh
10
Latin America and the Carribbean
10
Nigeria
9
Uganda
8
Eastern Europe
8
Sierra Leone
7
Africa
7
Malawi
6
Ghana
5
Nepal
5
Eswatini/ Swaziland
5
Zimbabwe
4
Zambia
4
Liberia
3
Germany
3
Rwanda
3
Namibia
3
Botswana
3
Guinea
2
Congo, Democratic Republic of
2
Pakistan
2
Mozambique
2
North Macedonia
2
Ukraine
2
Myanmar / Burma
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Tajikistan
2
Vietnam
2
Burkina Faso
1
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Saudi Arabia
1
Philippines
1
Iraq
1
Gambia
1
Indonesia
1
Sudan
1
Benin
1
Colombia
1
Libya
1
Sri Lanka
1
West and Central Africa
1
Bhutan
1
Laos
1
Australia
1
North America
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
167
Clinical Guidelines
60
Key Resources
58
Pharmacy & Technologies
23
Public Health
15
Women & Child Health
15
Capacity Building
11
Toolboxes
AMR
90
TB
71
COVID-19
27
Rapid Response
22
Planetary Health
21
Pharmacy
18
2.0 Rapid Response
18
NTDs
15
Ebola & Marburg
12
HIV
12
Caregiver
12
Natural Hazards
8
Cholera
6
Conflict
3
Refugee
3
Global Health Education
3
Malaria
3
Disability
2
Polio
2
Zika
2
Mental Health
2
Health Financing Toolbox
1
NCDs
1
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on
...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
When setting national drinking-water quality regulations and standards, many countries consider the WHO Guidelines for drinking-water quality (GDWQ). To better understand the extent to which the GDWQ are used and reflected in these standards, this global review summarizes information from 104
...
The annual Joint Meeting of the Food and Agriculture Organization of the United Nations (FAO) Panel of Experts on Pesticide Residues in Food and the Environment and the World Health Organization (WHO) Core Assessment Group on Pesticide Residues (JMP
...
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological
...
The WHO laboratory biosecurity guidance follows and complements the revision of the Laboratory biosafety manual, fourth edition and provides principles and measures to prevent lapses and incidents throughout the whole value chain of handling high-consequence biological material, technology and infor
...
Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emer
...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill
...
With this study, we estimated the burden of serious fungal infections for the general healthy population and for those at risk, including those infected with HIV, patients with asthma, as well as those under intensive care. We also highlight from s
...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren
...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg
...
In this review, the editors will investigate the impact of eight WASH interventions in preventing (reducing the risk of) and controlling outbreaks in LMIC, with particular focus on three diseases of current concern to the response community – chol
...
This publication provides recommendations for the management of critically ill adult patients with COVID-19 being treated in intensive care units (ICUs) in the Americas. These clinical practice guidelines provide evidence-informed recommendations for identifying markers and mortality
...
The response to a cholera outbreak must focus on limiting mortality and reducing the spread of the disease. It should be comprehensive and multisectoral, including epidemiology, case management, water, sanitation and hygiene, logistics, community engagement and
...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus
...
Healthcare Waste Management Toolkit for Global Fund Practitioners and Policy Makers. Part B
Healthcare Waste Management Toolkit for Global Fund Practitioners and Policy Makers: Part A
